Oventus reaches milestone
By HME News Staff
Updated 9:53 AM CDT, Mon May 2, 2022
BRISBANE, Australia – Oventus Medical’s direct-to-consumer market model reached its first optimization milestone in the third quarter of its fiscal year 2022: It delivered growth in active leads with a reduction in advertising spend of 20% less than the previous quarter, the company has announced. Despite the March quarter being slow due to seasonality, Oventus says new leads increased 63% with 6,100 generated. “With the weakest of insurance seasonality period behind us, we are looking forward to executing on our plans and bringing the benefits of the O2Vent therapy to our patients and partners,” said John Cox. CEO. “We can see the pipeline building from our direct-to-consumer marketing and remain focused on converting that pipeline info satisfied O2Vent users over the balance of 2022.” Oventus says completed telehealth consults increased by 6% to 1,043 in the third quarter. It reported revenue was $233,000, down from a record December quarter but above the two previous quarters.
Comments